Ensign Peak Advisors, Inc Abiomed Inc Transaction History

Ensign Peak Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$224.73 - $338.64 $187,649 - $282,764	835 Added 7.76%	11,596 $2.87 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $684,807 - $904,736	-2,470 Reduced 18.67%	10,761 $3.56 Million
Q4 2021 Feb 11, 2022	BUY	$300.63 - $371.35 $2.9 Million - $3.58 Million	9,650 Added 269.48%	13,231 $4.75 Million
Q3 2021 Nov 12, 2021	SELL	$310.19 - $376.2 $426,201 - $516,898	-1,374 Reduced 27.73%	3,581 $1.17 Million
Q2 2021 Aug 13, 2021	BUY	$262.71 - $351.17 $51,228 - $68,478	195 Added 4.1%	4,955 $1.55 Million
Q1 2021 May 12, 2021	SELL	$285.92 - $355.13 $563,262 - $699,606	-1,970 Reduced 29.27%	4,760 $1.52 Million
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $265,733 - $342,031	1,055 Added 18.59%	6,730 $2.18 Million
Q3 2020 Nov 12, 2020	SELL	$255.22 - $317.0 $960,903 - $1.19 Million	-3,765 Reduced 39.88%	5,675 $1.57 Million
Q2 2020 Aug 12, 2020	SELL	$141.4 - $257.09 $312,494 - $568,168	-2,210 Reduced 18.97%	9,440 $2.28 Million
Q1 2020 May 11, 2020	SELL	$130.51 - $196.01 $376,782 - $565,880	-2,887 Reduced 19.86%	11,650 $1.69 Million
Q4 2019 Feb 14, 2020	BUY	$159.31 - $223.54 $2.32 Million - $3.25 Million	14,537 New	14,537 $2.48 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.